Swedish patients’ trust in the bioequivalence of interchangeable generics. What factors are important for low trust?
| Autor: | Susanne Kaae, Caroline Hällkvist, Emma Carlsson, Helle Wallach-Kildemoes, Sofia Kälvemark Sporrong, Erika Olsson, Karin Svensberg |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
mesh:Sweden
medicine.medical_specialty Multivariate analysis mesh:Generic mesh:Multivariate Analysis mesh:Health Knowledge Social and Clinical Pharmacy Pharmaceutical Science lcsh:RS1-441 Pharmacy Bioequivalence mesh:Patient Preference Logistic regression Generic lcsh:Pharmacy and materia medica 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires medicine 030212 general & internal medicine mesh:Practice health care economics and organizations Original Research 030203 arthritis & rheumatology Response rate (survey) mesh:Drug Substitution Health Knowledge Attitudes Practice Sweden Practice Community pharmacies Drug Substitution Health Knowledge Samhällsfarmaci och klinisk farmaci Generic Substitution lcsh:RM1-950 Drugs mesh:Attitudes Patient Preference Odds ratio Drugs Generic Stratified sampling lcsh:Therapeutics. Pharmacology mesh:Drugs Attitudes Family medicine Multivariate Analysis mesh:Surveys and Questionnaires Psychology |
| Zdroj: | Pharmacy Practice, Vol 16, Iss 4, p 1298 (2018) Pharmacy Practice Olsson, E, Svensberg, K, Wallach-Kildemoes, H, Carlsson, E, Hällkvist, C, Kaae, S & Kälvemark Sporrong, S 2018, ' Swedish patients’ trust in the bioequivalence of interchangeable generics. What factors are important for low trust? ', Pharmacy Practice, bind 16, nr. 4, s. 1298 . https://doi.org/10.18549/PharmPract.2018.04.1298 Pharmacy Practice (Granada), Volume: 16, Issue: 4, Article number: 1298, Published: 21 OCT 2019 |
| ISSN: | 1886-3655 |
| DOI: | 10.18549/PharmPract.2018.04.1298 |
| Popis: | Background: Generic substitution (GS), is a cost-containment strategy meant to contain pharmaceutical expenditure without compromising health objectives. In order to shape GS into a policy that is both efficient and safe it is crucial to understand which factors are most important for patients' trust in GS. Objective: To assess Swedish patients' level of trust in the bioequivalence of cheap and expensive generic medicines, and the association between trust and various factors. Methods: A cross-sectional study was conducted. Questionnaires were handed out at 12 community pharmacies in Sweden, selected through stratified sampling, between March and April 2015. The questionnaire included seven socio-demographic questions in addition to 18 items divided into three sections: the 'views on generic medicine'-scale, information on and prior experiences of GS, financial aspects and change of color/name. Odds Ratios (ORs) were estimated applying adjusted logistic regression analyses with trust in the bioequivalence of generic medicines used as outcome variable and various factors as predictors. Results: A total of 719 patients participated (response rate 85.7%). The results show that 70.7% of the respondents' trust that cheap and expensive interchangeable generic medicines are equal. Of the respondents 36.0% considered the change in appearance and 40.8% the change in names to complicate adherence. Lower trust in the bioequivalence of generic medicines were associated with being female (aOR=1.82, 95%CI 1.20:2.75, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|